MedPath

TEVA-EXEMESTANE

TEVA-EXEMESTANE

Discontinued
DIN Number

02408473

Drug Class

Human

Market Date

Oct 1, 2013

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02408473
AIG Number0141702001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BG06 EXEMESTANE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

EXEMESTANEActive
Strength: 25 MG
Monograph: EXEMESTANE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.